This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Disorders of speech understanding and production
F5_SPECIFIC_SPEECH
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
1652 |
4. Check minimum number of eventsNone |
1652 |
5. Include endpointsNone |
1652 |
6. Filter based on genotype QC (FinnGen only) |
1652 |
Control definitions (FinnGen only)
- Control exclude
- R18_DELAY_MILES_CHILDH
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Disorders of speech understanding and production
based on the number of shared cases.
Similar with more cases:
- Specific development disorders of speech and language
- Speech and linguistic disorders, excluding more controls
- Speech and linguistic disorders
- Disorders of psychological development
- Any mental disorder
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1652 | 798 | 854 |
| Unadjusted period prevalence (%) | 0.33 | 0.27 | 0.38 |
| Median age at first event (years) | 11.68 | 16.81 | 6.88 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1465
- Matched controls
- 14355
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
F80.1
ICD-10 Finland
Expressive language disorder
5132.8
323.0
1127
9
F80.2
ICD-10 Finland
Receptive language disorder
1216.7
323.0
496
6
R62.0
ICD-10 Finland
Delayed milestone
61.8
134.6
158
28
F80.9
ICD-10 Finland
Developmental disorder of speech and language, unspecified
28.0
109.4
152
59
F82
ICD-10 Finland
Specific developmental disorder of motor function
13.7
78.9
141
111
F83
ICD-10 Finland
Mixed specific developmental disorders
11.1
77.4
153
149
AA1AD
NOMESCO Finland
CT of head and brain
3.6
73.3
405
1392
XA800
NOMESCO Finland
Neuropsychological investigation
6.5
72.0
201
342
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
6.4
59.2
165
278
R4130
NOMESCO Finland
Speech therapy
9.9
58.6
122
130
Z2445
NOMESCO Finland
Psychologist
4.2
57.2
241
642
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
9.4
57.2
123
139
3153A
ICD-9 Finland
Specific delays in development, Developmental speech or language disorder[KIELENKEHITYKSEN ERITYISVAIKEUS]
87.5
53.8
60
7
Z50.5
ICD-10 Finland
Speech therapy
6.8
51.9
138
217
Z3226
NOMESCO Finland
Physiotherapist
2.7
48.0
392
1693
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
4.2
47.0
193
497
Z01.1
ICD-10 Finland
Examination of ears and hearing
2.9
45.1
320
1257
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
4.6
44.8
167
391
G45.1
ICD-10 Finland
Carotid artery syndrome (hemispheric)
9.6
44.6
94
102
F80.8
ICD-10 Finland
Other developmental disorders of speech and language
16.8
44.5
72
44
Z2446
NOMESCO Finland
Social worker
3.0
41.0
267
985
R1260
NOMESCO Finland
Evaluation of communicative skills
10.1
40.2
82
84
R47.0
ICD-10 Finland
Dysphasia and aphasia
26.6
39.6
55
21
F81.0
ICD-10 Finland
Specific reading disorder
9.8
38.7
80
84
R4120
NOMESCO Finland
Occupational therapy
4.3
37.4
149
371
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
3.3
36.4
203
669
F80.0
ICD-10 Finland
Specific speech articulation disorder
12.8
35.1
63
50
Z2221
NOMESCO Finland
Medical doctor
2.2
35.0
457
2449
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
4.1
34.1
140
358
R47.8
ICD-10 Finland
Other and unspecified speech disturbances
18.2
33.3
52
29
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
4.7
32.7
117
261
R4110
NOMESCO Finland
Physiotherapy
2.2
32.2
396
2052
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
3.2
32.1
181
599
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.9
30.8
212
802
PA7AD
NOMESCO Finland
CT angiography of head and neck vasculature
8.8
30.6
67
78
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.4
29.4
286
1315
N03AG01
ATC
valproic acid; systemic, rectal
3.6
28.0
136
401
Z3231
NOMESCO Finland
Registered nurse
2.0
27.8
502
3017
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.7
27.7
211
847
G40.9
ICD-10 Finland
Epilepsy, unspecified
4.9
27.3
92
193
3153X
ICD-9 Finland
Specific delays in development, Developmental speech or language disorder[PUHEEN KEHITYKSEN ERITYISVAIKEUS]
270.3
26.6
27
*
B01AC04
ATC
clopidogrel; oral
3.0
26.6
164
574
N03AF02
ATC
oxcarbazepine; oral
4.6
25.8
93
209
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.9
25.6
526
3288
RL140
NOMESCO Finland
NA
14.4
25.4
43
30
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
3.4
25.1
126
381
R47.1
ICD-10 Finland
Dysarthria and anarthria
19.5
24.5
37
19
F70.0
ICD-10 Finland
Mild mental retardation, With the statement of no, or minimal, impairment of behaviour
11.3
24.4
46
41
N05AH04
ATC
quetiapine; oral
2.2
24.3
284
1415
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
3.0
24.2
151
532
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.4
24.2
231
1046
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.6
23.1
182
741
AA5BD
NOMESCO Finland
CT of cerebral ischaemia
8.8
22.8
49
56
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.8
22.7
153
569
ZY010
NOMESCO Finland
Hospital outpatient
2.7
22.5
166
651
N05AX12
ATC
aripiprazole; systemic
3.3
22.5
118
369
XF400
NOMESCO Finland
ECG with 12 standard connections
2.1
22.4
275
1397
N05AH03
ATC
olanzapine; systemic
2.9
22.0
140
501
F81.3
ICD-10 Finland
Mixed disorder of scholastic skills
6.8
21.3
54
80
F29
ICD-10 Finland
Unspecified nonorganic psychosis
3.3
21.2
114
363
N05AX08
ATC
risperidone; systemic
2.7
21.1
154
599
P24
ICPC
Specific learning problem
4.7
20.4
71
155
R56.8
ICD-10 Finland
Other and unspecified convulsions
2.8
20.3
134
490
Z3229
NOMESCO Finland
Other healthcare associate professional
2.5
20.2
170
716
DFF20
NOMESCO Finland
Audiometry for children
6.5
20.1
53
83
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
4.3
20.0
75
176
Z01.8
ICD-10 Finland
Other specified special examinations
2.0
20.0
297
1621
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
2.9
19.7
126
449
R42
ICD-10 Finland
Dizziness and giddiness
2.1
19.6
250
1282
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
3.1
19.6
111
366
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.0
19.5
266
1405
A28
ICPC
Limited function/disability NOS
2.3
19.3
188
855
TPH04
NOMESCO Finland
Cathetrisation of vein
2.0
18.6
273
1482
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.7
18.5
136
532
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.2
18.2
195
926
N03AX14
ATC
levetiracetam; systemic
4.2
18.0
69
166
ZXE10
NOMESCO Finland
More than one and less than three hours
1.7
18.0
452
2943
RT150
NOMESCO Finland
NA
7.8
17.8
41
53
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.1
17.8
229
1176
F90.0
ICD-10 Finland
Disturbance of activity and attention
2.5
17.8
143
587
EBA15
NOMESCO Finland
Extraction of large number of teeth
3.8
17.1
74
199
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
2.4
17.1
148
633
N19
ICPC
Speech disorder
3.5
17.0
81
236
IBZ01
NOMESCO Finland
Profession-specific psychiatric evaluation
3.3
17.0
86
263
B01AC30
ATC
platelet aggregation inhibitors excl. heparin - combinations
3.8
16.9
72
191
RL130
NOMESCO Finland
NA
8.6
16.7
36
42
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
2.3
16.6
160
718
C10AA05
ATC
atorvastatin; oral
1.9
16.6
288
1653
IGY01
NOMESCO Finland
Accelerated psychiatric treatment contact
3.4
16.4
80
238
N05BA01
ATC
diazepam; systemic, rectal
2.3
16.2
158
716
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
2.6
15.9
124
501
Z13.4
ICD-10 Finland
Special screening examination for certain developmental disorders in childhood
47.1
15.9
19
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.8
15.8
314
1887
R55
ICD-10 Finland
Syncope and collapse
2.4
15.8
145
638
ZXD10
NOMESCO Finland
Scheduled procedure
1.6
15.8
495
3406
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
2.8
15.7
104
381
P22
ICPC
Child behaviour symptom/complaint
3.3
15.7
80
246
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
5.4
15.6
47
88
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.0
15.4
223
1196
F81.9
ICD-10 Finland
Developmental disorder of scholastic skills, unspecified
6.0
15.1
41
68
WX892
NOMESCO Finland
Monitored bed care
2.5
15.0
126
529
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
3.2
15.0
80
255
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.9
14.8
235
1304
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
3.4
14.8
73
219
PA7CD
NOMESCO Finland
CT angiography of neck and brain, extensive
12.3
14.7
26
21
G80.1
ICD-10 Finland
Spastic diplegic cerebral palsy
16.3
14.6
23
14
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
4.2
14.6
56
136
ZXE20
NOMESCO Finland
More than three and less than five hours
2.0
14.6
192
993
F81.8
ICD-10 Finland
Other developmental disorders of scholastic skills
6.5
14.4
37
57
R41.0
ICD-10 Finland
Disorientation, unspecified
4.3
14.2
52
121
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
3.2
14.0
75
240
I63.3
ICD-10 Finland
Cerebral infarction due to thrombosis of cerebral arteries
4.3
14.0
52
123
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
2.5
13.9
116
486
N03AX09
ATC
lamotrigine; oral
2.8
13.5
87
314
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
4.7
13.2
44
93
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.4
13.2
115
493
IGY99
NOMESCO Finland
Other psychiatric treatment contact
2.7
13.0
88
326
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.4
13.0
116
501
N06AB04
ATC
citalopram; systemic
1.9
12.8
199
1091
ZYC01
NOMESCO Finland
Remote contact by phone
2.6
12.8
95
375
N05BA04
ATC
oxazepam; oral
1.8
12.7
261
1575
F84.9
ICD-10 Finland
Pervasive developmental disorder, unspecified
6.3
12.7
33
52
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
3.8
12.7
53
140
N05AD01
ATC
haloperidol; systemic
4.3
12.5
46
108
WX882
NOMESCO Finland
High dependency care
2.4
12.5
110
472
WX408
NOMESCO Finland
General anesthesy, balanced
1.6
12.4
367
2457
G80.2
ICD-10 Finland
Spastic hemiplegic cerebral palsy
13.0
12.3
21
16
R51.80
ICD-10 Finland
Headache
1.8
12.1
231
1358
L28
ICPC
Limited function/disability (L)
2.0
12.0
167
882
N06AX11
ATC
mirtazapine; oral
1.6
11.8
321
2096
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
2.7
11.8
82
311
H01AC01
ATC
somatropin; parenteral
4.1
11.8
45
110
IGY02
NOMESCO Finland
Psychiatric monitoring contact
2.6
11.6
83
318
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
2.4
11.6
96
400
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
2.5
11.6
91
371
ZXY51
NOMESCO Finland
2-person team, doctor-nurse
3.3
11.6
58
178
C08CA01
ATC
amlodipine; oral
1.7
11.5
272
1707
T36
ICD-10 Finland
Poisoning by systemic antibiotics
2.7
11.5
79
298
PA7BD
NOMESCO Finland
CT angiography of neck and brain
6.4
11.4
29
45
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
2.2
11.3
116
539
N17
ICPC
Vertigo/dizziness
2.0
11.3
142
720
P99
ICPC
Psychological disorders other
3.2
11.3
59
187
N03AE01
ATC
clonazepam; systemic
3.0
11.2
65
220
N05BA06
ATC
lorazepam; systemic, sublingual
3.2
11.2
59
188
ZXE00
NOMESCO Finland
One hour or less
1.5
11.2
517
3829
M79.6
ICD-10 Finland
Pain in limb
1.6
11.1
383
2650
I63.4
ICD-10 Finland
Cerebral infarction due to embolism of cerebral arteries
4.4
11.1
39
88
TKC20
NOMESCO Finland
Catheterisation of bladder
2.6
11.1
81
317
H53.1
ICD-10 Finland
Subjective visual disturbances
2.6
10.5
78
308
SPAT1216
SPAT
Assessment of functional ability
1.9
10.5
166
915
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.7
10.4
262
1673
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.7
10.2
235
1462
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
3.5
10.2
47
136
H50.31
ICD-10 Finland
Intermittent exotropia
3.9
10.2
41
106
F80
ICD-10 Finland
Specific developmental disorders of speech and language
18.5
10.1
15
8
IFA99
NOMESCO Finland
Other psychiatric pharmacotherapy service
4.3
10.1
36
83
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.6
10.1
344
2368
R41.3
ICD-10 Finland
Other amnesia
4.4
10.0
35
79
ICC04
NOMESCO Finland
Psychiatric treatment plan, permanent discontinuation
2.8
10.0
64
233
AA5HE
NOMESCO Finland
Brain ultrasound examination in a child
3.1
9.9
52
166
H66.0
ICD-10 Finland
Acute suppurative otitis media
1.6
9.9
266
1725
F81.1
ICD-10 Finland
Specific spelling disorder
9.0
9.9
20
22
F98.8
ICD-10 Finland
Other specified behavioural and emotional disorders with onset usually occurring in childhood and adolescence
4.5
9.9
34
76
R1410
NOMESCO Finland
Drawing up a rehabilitation plan
6.4
9.9
25
39
ICB02
NOMESCO Finland
Psychiatric treatment plan, extended/prolonged
4.1
9.8
37
90
DFF00
NOMESCO Finland
Pure tone audiometry
2.2
9.8
98
450
K90
ICPC
Stroke/cerebrovascular accident
4.0
9.8
38
95
R1210
NOMESCO Finland
Medical assessment of need and possibilities to rehabilitation
4.3
9.8
35
81
SPAT1365
SPAT
Health check-up performed during first study year due to special need in students of upper secondary schools or vocational schools
4.6
9.8
33
72
ICB03
NOMESCO Finland
Psychiatric treatment plan, monitoring
3.2
9.8
51
162
N05AN01
ATC
lithium; oral
3.9
9.8
39
100
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
5.2
9.8
29
55
F84.5
ICD-10 Finland
Asperger syndrome
4.0
9.7
38
96
AA5PD
NOMESCO Finland
CT examination of brain pefusion
10.5
9.7
18
17
TPH07
NOMESCO Finland
Cathetrisation of artery
1.9
9.6
133
700
N06AX16
ATC
venlafaxine; oral
1.9
9.6
153
846
IGV01
NOMESCO Finland
Psychiatric network contact
3.2
9.5
48
149
XX4AW
NOMESCO Finland
NA
4.0
9.5
37
93
SPAT1224
SPAT
Implementation of speech therapy rehabilitation plan
3.0
9.5
52
172
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
2.1
9.4
105
507
F70.1
ICD-10 Finland
Mild mental retardation, Significant impairment of behaviour requiring attention or treatment
11.2
9.4
17
15
C07AB02
ATC
metoprolol; systemic
1.8
9.4
168
965
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
2.4
9.4
80
341
ZXE17
NOMESCO Finland
Procedure duration 150 to 179 minutes
3.5
9.4
42
119
K89
ICPC
Transient cerebral ischaemia
9.0
9.4
19
21
XF600
NOMESCO Finland
Bloodpressure measurement
1.9
9.2
128
674
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
2.7
9.2
59
216
P20
ICPC
Memory disturbance
2.1
9.2
109
539
N06BA04
ATC
methylphenidate; oral
2.2
9.2
93
429
L17
ICPC
Foot/toe symptom/complaint
1.5
9.1
333
2321
183
Kela drug reimbursment
Lamotrigin and topiramate
4.6
9.0
30
65
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.9
9.0
145
803
R13
ICD-10 Finland
Dysphagia
2.6
9.0
65
255
F70.9
ICD-10 Finland
Mild mental retardation, Without mention of impairment of behaviour
15.4
8.9
14
9
F84.0
ICD-10 Finland
Childhood autism
8.9
8.9
18
20
F94.0
ICD-10 Finland
Elective mutism
18.3
8.8
13
7
K03.66
ICD-10 Finland
Tooth plaque
1.8
8.8
147
828
R27.0
ICD-10 Finland
Ataxia, unspecified
12.4
8.8
15
12
N30.0
ICD-10 Finland
Acute cystitis
1.7
8.7
169
998
N18
ICPC
Paralysis/weakness
4.9
8.6
27
55
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
1.8
8.6
142
795
F90.9
ICD-10 Finland
Hyperkinetic disorder, unspecified
4.0
8.6
33
83
F05.9
ICD-10 Finland
Delirium, unspecified
4.3
8.6
30
69
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
3.1
8.5
44
140
N05AH02
ATC
clozapine; systemic
3.1
8.5
44
140
N05AA02
ATC
levomepromazine; systemic
2.9
8.5
49
167
A02BC02
ATC
pantoprazole; systemic
1.4
8.5
573
4508
SPAT1297
SPAT
Other function in accordance with speech therapy nomenclature
3.9
8.5
33
84
SPAT1307
SPAT
Psychosocial counselling and guidance
1.7
8.4
166
983
SPAT1301
SPAT
No procedures
1.4
8.4
428
3191
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
2.0
8.4
110
570
F84.8
ICD-10 Finland
Other pervasive developmental disorders
7.2
8.3
19
26
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.1
8.3
96
471
N05AB03
ATC
perphenazine; systemic, rectal
3.1
8.3
43
138
Z71.8
ICD-10 Finland
Other specified counselling
1.5
8.2
342
2447
S18
ICPC
Laceration/cut
1.4
8.2
467
3559
R5599
NOMESCO Finland
Other rehabilitation service
2.8
8.2
52
189
RT160
NOMESCO Finland
NA
5.2
8.2
24
46
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
2.0
8.1
102
518
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
1.7
8.1
173
1049
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.4
8.1
741
6129
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
2.0
8.0
95
472
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
3.3
8.0
38
114
3159X
ICD-9 Finland
Specific delays in development, Unspecified delay in development
32.9
8.0
10
*
R1250
NOMESCO Finland
Evaluation of functional capability
3.2
8.0
39
120
R5130
NOMESCO Finland
Repair work or maintenance done on the aid
3.6
8.0
34
94
SPAT1245
SPAT
Provision of support and information to patient’s family members
2.5
7.9
59
237
ZXA00
NOMESCO Finland
Right side
1.5
7.9
252
1700
R33
ICD-10 Finland
Retention of urine
2.5
7.9
61
248
F88
ICD-10 Finland
Other disorders of psychological development
5.0
7.9
24
48
Z87.6
ICD-10 Finland
Personal history of certain conditions arising in the perinatal period
2.8
7.8
48
172
RT420
NOMESCO Finland
NA
7.1
7.8
18
25
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.5
7.8
261
1778
R53
ICD-10 Finland
Malaise and fatigue
1.6
7.8
240
1602
ZXE40
NOMESCO Finland
More than seven and less than nine hours
2.9
7.8
46
160
WZB00
SPAT
NA
0.5
7.8
57
1102
RS222
NOMESCO Finland
NA
3.5
7.8
35
101
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.5
7.7
268
1841
RS140
NOMESCO Finland
NA
6.0
7.7
20
33
IEY01
NOMESCO Finland
Psychoeducation, individual
3.9
7.7
30
77
F60.9
ICD-10 Finland
Personality disorder, unspecified
4.3
7.7
27
63
N28
ICPC
Limited function/disability (N)
4.6
7.7
25
54
SPAT1229
SPAT
Assessment of need for aid
2.2
7.6
76
351
RS220
NOMESCO Finland
NA
3.2
7.6
38
119
R07.4
ICD-10 Finland
Chest pain, unspecified
1.6
7.6
236
1581
B01AA03
ATC
warfarin; systemic
1.7
7.6
153
913
N99
ICPC
Neurological disease other
7.3
7.6
17
23
F60.3
ICD-10 Finland
Emotionally unstable personality disorder
5.2
7.6
22
42
R06.0
ICD-10 Finland
Dyspnoea
1.5
7.5
241
1624
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
2.3
7.5
70
313
I10
ICD-10 Finland
Essential (primary) hypertension
1.4
7.5
386
2876
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
2.4
7.5
62
263
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
2.0
7.4
97
502
I63.5
ICD-10 Finland
Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries
5.1
7.4
22
43
F31.7
ICD-10 Finland
Bipolar affective disorder, currently in remission
3.5
7.4
32
90
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
2.6
7.4
52
203
602
Kela drug reimbursment
Children's severe malnutrition
3.0
7.3
39
128
KAY40
NOMESCO Finland
NA
0.3
7.3
19
544
ZXD05
NOMESCO Finland
Urgent procedure
1.4
7.3
355
2612
N06AB03
ATC
fluoxetine; oral
1.8
7.3
134
777
WX002
NOMESCO Finland
Sedation and analgesia
1.6
7.3
188
1202
NE1AA
NOMESCO Finland
Pelvis X-ray examination
2.2
7.3
69
313
XF404
NOMESCO Finland
Ambulatory ECG
1.9
7.3
101
534
C03CA01
ATC
furosemide; systemic
1.6
7.2
218
1446
3154A
ICD-9 Finland
Specific delays in development, Coördination disorder
+∞
7.2
7
*
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.9
7.2
105
566
G45.8
ICD-10 Finland
Other transient cerebral ischaemic attacks and related syndromes
8.2
7.2
15
18
K05.10
ICD-10 Finland
Gingivitis (chronic) NOS
1.6
7.2
184
1176
DCA20
NOMESCO Finland
Insertion of ventilating tube through tympanic membrane
1.7
7.2
143
853
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.0
7.2
94
485
H53.0
ICD-10 Finland
Amblyopia ex anopsia
3.0
7.1
38
125
SJB00
NOMESCO Finland
Fitting of loose orthodontic device with user information
1.8
7.1
115
640
IBA04
NOMESCO Finland
Extensive initial psychiatric evaluation
2.3
7.1
62
269
ZXA10
NOMESCO Finland
Bilateral
1.5
7.1
228
1538
ZXE30
NOMESCO Finland
More than five and less than seven hours
2.1
7.1
74
347
A04
ICPC
Weakness/tiredness general
1.6
7.1
208
1375
R20.2
ICD-10 Finland
Paraesthesia of skin
2.1
7.1
74
348
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
3.1
7.1
36
115
N05CD08
ATC
midazolam; nasal, systemic
2.7
7.1
45
164
N05AF03
ATC
chlorprothixene; systemic
3.2
7.0
35
110
PA6AD
NOMESCO Finland
CT of neck arteries
6.5
7.0
17
26
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.7
7.0
136
802
K02.1
ICD-10 Finland
Caries of dentine
1.3
7.0
786
6650
R26.8
ICD-10 Finland
Other and unspecified abnormalities of gait and mobility
3.4
6.9
31
90
D12
ICPC
Constipation
2.6
6.9
48
184
SPAT1254
SPAT
Administration of medicine
1.5
6.9
250
1730
61
HP
Catheterization and pressure measurement of the left side of the heart
4.6
6.9
22
47
Z95.0
ICD-10 Finland
Presence of electronic cardiac devices
2.6
6.9
48
185
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
1.6
6.8
174
1107
Q89.7
ICD-10 Finland
Multiple congenital malformations, not elsewhere classified
13.6
6.8
11
8
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.9
6.8
99
532
XF402
NOMESCO Finland
ECG with work load test
2.0
6.8
89
460
RS314
NOMESCO Finland
NA
8.1
6.7
14
17
SPAT1296
SPAT
Other function in accordance with occupational therapy nomenclature
3.6
6.7
28
77
K07.59
ICD-10 Finland
Abnormal function of teeth and jaws UNS
10.8
6.7
12
11
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
1.4
6.7
347
2581
FM2CE
NOMESCO Finland
NA
2.2
6.7
67
311
SBB10
NOMESCO Finland
Teeth copy
1.6
6.7
199
1317
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.5
6.7
220
1490
TAB00
NOMESCO Finland
Lumbar puncture
2.2
6.7
64
291
N06AB06
ATC
sertraline; oral
1.7
6.6
133
793
N05BA09
ATC
clobazam; oral
3.6
6.6
28
78
Q93.5
ICD-10 Finland
Other deletions of part of a chromosome
22.2
6.6
9
*
H81
ICPC
Excessive ear wax
1.6
6.6
155
966
D43.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, supratentorial
7.1
6.6
15
21
SPAT1234
SPAT
Support of social functional capacity
2.2
6.6
64
294
F31.6
ICD-10 Finland
Bipolar affective disorder, current episode mixed
4.2
6.6
23
54
TJD20
NOMESCO Finland
Change of gastrostomy tube
4.6
6.6
21
45
AAB10
NOMESCO Finland
Partial excision of intracranial lesion
4.8
6.5
20
41
F92.9
ICD-10 Finland
Mixed disorder of conduct and emotions, unspecified
3.9
6.5
25
64
F98.00
ICD-10 Finland
Nonorganic enuresis nocturna
3.0
6.5
34
111
Q99.8
ICD-10 Finland
Other specified chromosome abnormalities
7.7
6.5
14
18
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.6
6.5
148
916
B01AF02
ATC
apixaban; oral
2.0
6.5
75
371
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
1.9
6.5
93
499
G40.19
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
4.1
6.5
23
55
A06AD11
ATC
lactulose; oral
1.7
6.5
133
798
IBB02
NOMESCO Finland
Psychiatric evaluation of working capacity and rehabilitation
4.5
6.5
21
46
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
2.3
6.5
56
245
UDC00
NOMESCO Finland
Ear microscopy
1.8
6.4
109
616
WX730
NOMESCO Finland
Conventional respirator
3.6
6.4
27
75
IEP99
NOMESCO Finland
Other psychiatric family intervention
3.2
6.4
31
96
E34.31
ICD-10 Finland
Short stature, prenatal disorder
6.7
6.4
15
22
301
Kela drug reimbursment
Growth hormone
4.7
6.4
20
42
K59.09
ICD-10 Finland
Constipation, unspecified
2.0
6.4
80
406
WX110
NOMESCO Finland
Local anesthesy
1.3
6.4
939
8217
7834D
ICD-9 Finland
Symptoms concerning nutrition, metabolism and development, Lack of expected normal physiological development[LAPSEN NORMAALIN KEHITTYMISEN HIDASTUMINEN]
68.7
6.4
7
*
XKD00
NOMESCO Finland
Uroflowmetry
1.8
6.4
114
659
IGP01
NOMESCO Finland
Psychiatric family contact
2.4
6.3
52
221
R5120
NOMESCO Finland
Preparation of an aid
3.5
6.3
27
76
WX872
NOMESCO Finland
Intensive care
2.5
6.3
46
184
WX704
NOMESCO Finland
Intubation
2.0
6.3
76
383
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.4
6.3
431
3361
N06AB10
ATC
escitalopram; oral
1.5
6.3
240
1680
101
Kela drug reimbursment
Anterior pituitary hypofunction
3.4
6.3
28
82
K59.0
ICD-10 Finland
Constipation
2.0
6.2
73
363
PA6AE
NOMESCO Finland
Ulrasound examination of neck vasculature
4.8
6.2
19
39
N03AX16
ATC
pregabalin; oral
1.6
6.2
178
1169
IAB01
NOMESCO Finland
Psychiatric pharmacotherapy consultation
5.9
6.2
16
27
JC2KB
NOMESCO Finland
Functional X-ray examination of swallowing
5.9
6.2
16
27
H50.2
ICD-10 Finland
Vertical strabismus
5.4
6.2
17
31
UDQ12
NOMESCO Finland
Flexible laryngoscopy
2.3
6.2
53
229
F20.9
ICD-10 Finland
Schizophrenia, unspecified
2.8
6.2
36
126
IBZ06
NOMESCO Finland
Evaluation concerning developmental neuropsychiatry
3.9
6.2
23
58
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
3.0
6.1
33
111
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
2.4
6.1
50
212
Z00.8
ICD-10 Finland
Other general examinations
1.8
6.1
108
621
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
3.4
6.1
27
79
G40.10
ICD-10 Finland
Simple partial seizures
4.4
6.0
20
45
Z63.7
ICD-10 Finland
Other stressful life events affecting family and household
2.1
6.0
62
291
F94.8
ICD-10 Finland
Other childhood disorders of social functioning
7.5
6.0
13
17
L01AX03
ATC
temozolomide; systemic
7.5
6.0
13
17
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3018677) aPTT in Platelet poor plasma by Coagulation assay
478
1787
3.29
95.37
3.8
3.8
s
29.6
30.0
0.95
468
1745
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
617
2785
2.87
86.98
3.2
2.2
u/l
190.3
269.9
1.31
606
2640
(3013826) Glucose [Moles/volume] in Serum or Plasma
968
6740
1.99
39.49
7.9
5.2
mmol/l
6.4
6.4
0.19
924
6210
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
836
5608
1.94
37.23
11.1
7.7
mmol/l
1.2
1.2
1.13
766
4883
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
368
1838
2.24
36.96
5.6
3.6
ng/l
333.1
529.9
1.12
278
1256
(3024561) Albumin [Mass/volume] in Serum or Plasma
688
4426
1.90
33.80
6.7
5.8
g/l
36.4
36.7
0.81
656
4119
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
777
5216
1.87
33.26
11.4
7.7
mmol/l
1.2
1.2
1.29
735
4787
(3009466) Valproate [Moles/volume] in Serum or Plasma
91
225
4.14
32.47
5.7
5.0
umol/l
373.6
388.8
0.42
85
208
(3032080) INR in Blood by Coagulation assay
604
3762
1.91
32.45
11.7
7.8
inr
1.2
1.2
0.06
166
1138
(3003396) Base excess in Arterial blood by calculation
221
994
2.36
27.85
10.4
8.1
mmol/l
0.9
0.8
0.15
159
786
(3021447) Carbon dioxide [Partial pressure] in Venous blood
320
1678
2.08
27.60
7.2
7.0
kpa
5.8
5.8
0.38
309
1636
(3027801) Oxygen [Partial pressure] in Arterial blood
220
997
2.34
27.23
10.4
8.1
kpa
12.5
13.2
1.09
200
954
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
220
998
2.34
27.16
10.5
8.1
kpa
5.1
5.1
0.15
201
953
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
586
3776
1.81
27.15
2.2
1.8
pmol/l
94.6
96.1
0.36
308
1959
(3002032) Base excess in Venous blood by calculation
317
1669
2.07
26.99
7.3
7.0
mmol/l
1.2
1.5
0.60
257
1309
(3033658) Prothrombin time (PT) actual/Normal
494
3027
1.86
26.92
6.7
5.2
%
87.1
88.4
0.57
488
2971
(3024354) Oxygen [Partial pressure] in Venous blood
295
1526
2.09
26.28
7.3
6.7
kpa
5.0
5.0
0.08
285
1488
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
573
3713
1.79
25.75
4.8
3.5
u/l
31.1
31.9
0.35
554
3533
(3015377) Calcium [Moles/volume] in Serum or Plasma
536
3409
1.80
25.63
3.6
3.0
mmol/l
2.4
2.4
0.96
478
3018
(3026008) Bacteria identified in Urine by Culture
517
3281
1.79
24.73
3.8
2.8
—
—
—
0
0
(3036489) Thrombin time
146
577
2.63
24.17
4.6
5.2
s
21.6
22.5
1.17
132
539
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
130
487
2.76
23.90
13.7
10.9
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1049
8145
1.72
23.88
8.5
6.6
u/l
95.8
89.2
2.14
997
7609
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
102
337
3.10
23.51
7.5
5.9
%
1.6
1.6
0.04
93
310
(3007930) Methemoglobin/Hemoglobin.total in Blood
101
333
3.10
23.36
7.6
6.0
%
0.9
0.9
0.22
92
307
(3016502) Oxygen saturation in Arterial blood
192
902
2.23
21.64
11.4
8.6
%
95.7
95.9
0.14
176
867
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
349
2035
1.87
21.61
3.9
3.1
e6/l
4.2
2.2
2.17
201
1117
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
100
344
2.97
21.49
2.6
2.7
ug/l
173.7
369.8
1.35
87
319
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
356
2097
1.85
21.31
3.9
3.0
e6/l
1.1
0.9
0.39
211
1172
(3044290) Cell count panel - Cerebral spinal fluid
94
316
3.03
21.03
2.0
3.0
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
438
2756
1.76
21.00
4.8
4.1
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
730
5275
1.64
20.75
8.1
6.1
umol/l
15.1
14.1
0.37
686
4909
(3023183) Ammonium ion [Moles/volume] in Plasma
91
304
3.05
20.58
3.2
3.1
umol/l
31.6
33.6
0.36
82
262
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
240
1252
2.03
20.57
2.2
1.7
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1158
9411
1.69
20.49
4.2
3.6
pmol/l
14.7
14.7
0.29
1074
8462
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1306
10980
1.80
20.38
5.2
4.2
mu/l
3.2
1.9
0.51
1236
10145
(3014111) Lactate [Moles/volume] in Serum or Plasma
210
1048
2.11
20.27
9.4
8.7
mmol/l
1.3
1.4
0.74
198
979
(3019309) Folate [Moles/volume] in Red Blood Cells
295
1662
1.90
20.20
1.8
1.7
nmol/l
958.6
1173.8
4.57
236
1248
(3003458) Phosphate [Moles/volume] in Serum or Plasma
316
1823
1.87
20.10
9.7
8.0
mmol/l
1.2
1.2
0.58
295
1697
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
96
338
2.90
19.79
1.7
2.8
mmol/l
3.7
3.6
0.61
90
316
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
306
1764
1.86
19.45
2.3
1.8
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
237
1255
2.00
19.42
2.3
1.8
—
—
—
0
0
(3000991) Gas panel - Venous blood
270
1499
1.92
19.26
12.4
8.5
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
296
1699
1.86
19.04
8.8
6.3
mmol/l
0.8
0.8
0.27
283
1590
(3006315) Basophils [#/volume] in Blood
877
6718
1.60
19.01
9.0
7.0
e9/l
0.0
0.0
0.28
758
5735
(3023103) Potassium [Moles/volume] in Serum or Plasma
1388
11965
1.86
18.90
23.5
13.4
mmol/l
3.9
3.9
0.58
1360
11552
(3019550) Sodium [Moles/volume] in Serum or Plasma
1386
11943
1.86
18.89
23.6
13.3
mmol/l
139.5
139.5
0.46
1363
11565
(3001604) Monocytes [#/volume] in Blood
874
6696
1.60
18.88
9.0
7.0
e9/l
0.6
0.6
2.11
758
5714
(3018418) pH of Serum or Plasma
457
2984
1.69
18.85
3.9
3.8
ph
7.4
7.4
0.33
60
546
(3013115) Eosinophils [#/volume] in Blood
897
6926
1.59
18.66
9.6
7.5
e9/l
0.2
0.2
0.45
788
6017
(3002173) Hemoglobin [Mass/volume] in Arterial blood
169
801
2.19
18.56
11.4
8.4
g/l
121.8
122.9
0.24
158
771
(3022096) Basophils/100 leukocytes in Blood
820
6205
1.59
18.55
9.1
7.2
%
0.6
0.6
0.06
785
5880
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
601
4228
1.62
18.44
5.1
3.5
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
235
1263
1.96
18.41
8.9
7.6
mmol/l
105.0
104.4
0.92
228
1234
(3030467) Casts [#/volume] in Urine by Automated count
508
3439
1.65
18.12
4.9
3.4
e6/l
0.4
0.3
0.10
388
2564
(3002582) Erythrocytes [#/volume] in Urine
538
3726
1.62
17.37
5.0
3.5
e6/l
42.7
75.1
0.82
417
2828
(3006504) Eosinophils/100 leukocytes in Blood
833
6391
1.56
17.28
9.1
7.1
%
2.9
3.0
0.53
800
6034
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
982
7820
1.57
17.28
4.7
3.2
u/l
42.7
36.3
1.94
948
7389
(3021960) Folate [Moles/volume] in Serum or Plasma
354
2202
1.73
17.23
1.7
1.5
nmol/l
18.9
20.0
0.69
320
1893
(42870588) Differential panel, method unspecified - Blood
653
4752
1.58
17.02
8.5
7.2
—
—
—
0
0
(3026782) Osmolality of Urine
383
2447
1.70
16.87
3.8
2.8
mosm/kgh2o
551.1
575.3
1.22
343
2093
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
368
2329
1.71
16.78
3.2
2.7
mg/l
1.8
1.4
0.81
281
1641
(3016018) Differential panel - Cerebral spinal fluid
60
177
3.41
16.65
1.9
3.0
—
—
—
0
0
(3039000) Anion gap in Blood
60
177
3.41
16.65
10.0
8.6
mmol/l
12.3
11.1
1.17
52
154
(3019198) Lymphocytes [#/volume] in Blood
894
7004
1.55
16.63
9.0
6.9
e9/l
2.0
2.1
1.34
789
6136
(3019069) Monocytes/100 leukocytes in Blood
834
6435
1.55
16.62
9.3
7.3
%
8.6
8.4
1.31
801
6106
(3047181) Lactate [Moles/volume] in Blood
76
260
2.96
16.52
8.8
7.2
mmol/l
1.5
1.3
0.55
68
221
(3018572) Chloride [Moles/volume] in Blood
60
178
3.39
16.51
10.0
8.6
mmol/l
105.2
105.1
0.07
52
155
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
464
3133
1.63
16.44
2.6
2.5
mg/l
2.9
2.8
0.59
410
2729
(3013650) Neutrophils [#/volume] in Blood by Automated count
955
7607
1.55
16.37
13.5
9.3
e9/l
4.0
3.9
0.81
828
6536
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
90
341
2.68
16.18
1.9
2.9
e6/l
30.7
11.5
0.74
69
249
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
90
341
2.68
16.18
2.0
2.9
e6/l
2062.9
11795.5
0.40
72
258
(3020779) Urea [Moles/volume] in Serum or Plasma
216
1179
1.92
16.07
12.4
10.5
mmol/l
7.4
7.2
0.15
209
1141
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
51
140
3.66
15.78
1.7
1.4
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
154
753
2.11
15.58
5.6
3.7
ng/l
206.2
219.1
0.17
145
668
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
41
97
4.23
15.55
1.2
1.2
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1095
9071
1.55
15.06
5.6
4.5
mmol/mol
38.4
38.1
0.43
1035
8465
(3018010) Neutrophils/100 leukocytes in Blood
845
6632
1.51
14.93
9.0
6.8
%
54.7
53.6
1.75
812
6305
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
78
288
2.74
14.75
10.1
9.5
u/ml
0.4
0.3
0.49
51
170
(36304419) Bacteria [Presence] in Urine
489
3419
1.57
14.68
4.9
3.3
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
649
4831
1.52
14.67
3.3
2.6
nmol/l
69.4
71.8
1.31
597
4427
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
224
1273
1.84
14.64
7.4
7.3
mmol/l
23.6
23.8
0.25
214
1212
(3002030) Lymphocytes/100 leukocytes in Blood
854
6742
1.50
14.50
9.1
7.0
%
30.2
31.5
2.53
820
6395
(3008152) Bicarbonate [Moles/volume] in Arterial blood
115
516
2.28
14.39
7.3
7.1
mmol/l
24.2
24.4
0.16
99
478
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
53
160
3.32
14.22
1.1
1.1
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
269
1635
1.73
13.98
3.1
2.5
g/l
2.4
2.4
0.12
246
1526
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
52
157
3.32
13.95
1.1
1.1
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1437
12798
1.78
13.86
12.7
8.8
u/l
27.8
26.7
1.02
1402
12330
(3022948) Iron [Moles/volume] in Serum or Plasma
287
1784
1.70
13.73
3.1
2.5
umol/l
11.5
13.8
6.93
269
1667
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
452
3145
1.56
13.70
3.3
2.6
u/l
55.7
55.4
0.04
422
2897
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
39
98
3.97
13.68
1.5
1.4
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
40
103
3.88
13.58
3.1
2.4
umol/l
68.0
52.9
2.04
33
92
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
41
108
3.79
13.48
1.2
1.2
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
109
493
2.25
13.39
14.1
10.4
mmol/l
24.2
24.1
0.13
103
463
(3044640) Blood type and Crossmatch panel - Blood
496
3544
1.53
13.26
3.0
2.6
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
471
3332
1.54
13.17
5.4
3.3
ng/l
45.6
99.8
0.48
323
1993
(40758558) Short blood count panel - Blood
492
3521
1.53
13.02
9.8
7.6
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
82
332
2.50
12.92
1.4
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
82
332
2.50
12.92
1.4
1.3
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1167
9941
1.52
12.89
4.4
3.5
mmol/l
5.8
5.7
1.69
1077
9093
(3044889) 12 lead EKG panel
837
6695
1.46
12.59
3.8
3.2
—
—
—
0
0
(3019060) Gas panel - Arterial blood
112
528
2.16
12.44
6.2
5.2
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
216
1276
1.76
12.33
3.0
2.2
nmol/l
319.0
362.2
2.96
198
1189
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
247
1520
1.70
12.17
3.3
2.6
%
18.9
22.9
4.96
214
1356
(3018095) Leukocytes [#/volume] in Urine
592
4460
1.47
11.98
5.8
4.0
e6/l
60.7
85.4
0.60
429
3025
(3023410) Appearance of Cerebral spinal fluid
56
195
2.88
11.85
2.2
4.2
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
246
1528
1.68
11.69
2.0
1.7
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
18
26
6.86
11.58
8.6
19.7
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
47
150
3.14
11.57
1.0
1.0
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
951
7864
1.44
11.54
6.5
4.2
e6/l
2358.6
1677.2
0.14
16
109
(3002385) Erythrocyte distribution width [Ratio]
1300
11428
1.55
11.52
24.9
14.8
%
13.5
13.4
3.20
1277
11213
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
282
1824
1.62
11.42
2.2
1.7
%
1.5
1.4
2.13
247
1651
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1140
9766
1.47
11.37
3.9
3.2
mmol/l
1.3
1.2
3.63
1065
9060
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
222
1361
1.69
11.05
5.4
4.3
umol/l
9.2
7.6
0.53
187
1153
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1195
10368
1.47
10.85
4.7
3.7
mmol/l
2.6
2.7
5.90
1128
9613
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
224
1386
1.68
10.76
10.8
7.0
mmol/l
1.2
1.1
0.28
162
991
(3009343) pH of Capillary blood
226
1410
1.66
10.51
10.8
7.0
ph
7.4
7.4
0.21
13
86
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
226
1416
1.66
10.33
10.8
7.0
kpa
5.1
5.0
0.67
214
1347
(3052851) Hemolysis interference index of Serum or Plasma
80
356
2.27
10.26
3.2
3.5
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
665
5230
1.41
10.24
4.6
4.1
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
763
6148
1.40
10.20
11.8
9.4
e9/l
0.0
0.0
0.52
610
4869
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
124
655
1.93
10.11
1.4
1.4
—
—
—
0
0
(3003338) MCHC [Mass/volume]
1334
11890
1.52
10.10
25.7
14.9
g/l
333.7
334.4
1.87
1325
11779
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1179
10263
1.44
10.01
4.3
3.5
mmol/l
4.3
4.5
11.65
1125
9597
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
107
539
2.01
10.00
6.3
6.1
g/l
3.2
3.1
0.36
99
523
(3007461) Platelets [#/volume] in Blood
1569
14598
2.09
9.95
28.3
17.0
e9/l
257.1
256.7
0.08
1528
14106
(3011397) Hemoglobin [Presence] in Urine by Test strip
397
2854
1.48
9.84
4.5
3.4
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
37
113
3.26
9.82
1.7
1.3
promille
1.0
1.3
0.54
29
83
(3024731) MCV [Entitic volume]
1569
14609
2.07
9.75
28.2
16.9
fl
88.4
88.6
1.11
1557
14401
(3035941) MCH [Entitic mass]
1569
14610
2.07
9.73
28.2
16.9
pg
29.6
29.7
1.72
1557
14403
(3026361) Erythrocytes [#/volume] in Blood
1569
14614
2.06
9.66
28.3
17.0
e12/l
4.6
4.6
0.85
1518
14092
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1167
10172
1.43
9.57
4.2
3.4
mmol/l
1.3
1.4
14.65
1099
9464
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
250
1636
1.59
9.55
3.1
2.8
mmol/l
2.4
2.4
0.05
211
1419
(3000850) Epithelial cells [#/volume] in Urine
359
2543
1.49
9.55
4.0
2.8
e6/l
6.7
6.0
0.46
325
2232
(3000963) Hemoglobin [Mass/volume] in Blood
1569
14621
2.05
9.53
28.6
17.1
g/l
134.9
136.1
2.65
1557
14404
(3010813) Leukocytes [#/volume] in Blood
1569
14622
2.05
9.51
28.3
17.0
e9/l
6.9
6.8
1.07
1518
14100
(40761511) CBC panel - Blood by Automated count
1445
13155
1.62
9.50
17.5
10.3
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
36
111
3.23
9.42
3.8
2.5
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1415
12827
1.57
9.38
20.0
11.8
mg/l
23.8
23.3
0.21
1144
9535
(3041354) Potassium [Moles/volume] in Venous blood
37
117
3.15
9.30
3.7
2.4
mmol/l
4.1
4.0
0.42
37
117
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
18
33
5.40
9.21
1.3
1.2
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
117
631
1.88
8.98
1.9
1.6
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
44
158
2.78
8.87
8.0
8.0
mg/l
10.7
10.0
0.35
38
144
(3001122) Ferritin [Mass/volume] in Serum or Plasma
721
5851
1.37
8.79
3.4
2.9
ug/l
86.9
87.1
0.01
682
5456
(3035285) Chloride [Moles/volume] in Venous blood
36
116
3.09
8.78
3.8
2.4
mmol/l
105.1
105.6
0.26
36
116
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
45
167
2.69
8.53
1.8
1.6
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
326
2312
1.48
8.53
4.7
3.9
ng/l
1566.8
1428.7
0.22
288
1919
(3028707) Methadone [Presence] in Urine by Screen method
118
650
1.84
8.48
4.2
2.8
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
214
1388
1.59
8.45
4.9
4.5
%
1.5
1.6
0.90
194
1268
(3000330) Specific gravity of Urine by Test strip
96
495
1.96
8.43
4.7
3.3
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
967
8254
1.36
8.37
6.2
4.1
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
170
1048
1.66
8.24
2.3
2.3
u/l
27.7
32.0
1.49
152
874
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
108
584
1.87
8.23
14.0
9.6
%
0.6
0.7
0.66
103
578
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
344
2482
1.45
8.21
1.7
1.7
mmol/l
1.4
1.3
0.92
311
2165
(3020630) Protein [Mass/volume] in Serum or Plasma
120
675
1.80
8.07
2.4
2.9
g/l
65.6
65.8
0.07
110
608
(3022217) INR in Platelet poor plasma by Coagulation assay
164
1010
1.66
7.98
24.9
22.7
inr
1.5
1.2
0.72
13
153
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
380
2808
1.43
7.94
2.9
2.5
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
444
3373
1.40
7.92
4.1
3.6
mmol/l
8.2
8.2
0.04
394
2933
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
10
11
8.97
7.91
1.3
1.2
—
—
—
0
0
(3022313) Gas panel - Capillary blood
185
1177
1.61
7.91
11.5
7.0
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
107
586
1.85
7.85
14.1
9.5
%
1.2
1.3
1.40
102
579
(3013707) Erythrocyte sedimentation rate by Westergren method
991
8538
1.35
7.80
4.9
3.9
mm/h
10.2
9.6
0.82
936
7846
(3042936) Bacteria identified in Isolate by Culture
224
1496
1.54
7.77
2.3
2.0
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
133
787
1.72
7.52
1.7
1.8
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
65
304
2.14
7.46
2.7
2.0
ug/l
3.5
2.9
0.11
50
256
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
267
1871
1.48
7.35
1.7
1.6
pmol/l
431.6
18102261.5
1.56
223
1591
(3009542) Hematocrit [Volume Fraction] of Blood
1383
12642
1.45
7.09
23.6
13.2
%
39.7
40.2
1.73
1101
10239
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
37
138
2.67
7.00
1.8
1.8
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
11
16
6.78
6.98
1.4
1.3
—
—
—
0
0
(4198724)
41
162
2.52
6.92
4.0
2.1
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
152
955
1.62
6.84
4.5
3.7
e9/l
62.0
68.5
2.16
117
677
(3028626) Oxygen [Partial pressure] in Capillary blood
167
1075
1.58
6.80
12.0
7.3
kpa
9.6
9.6
0.02
157
1025
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
23
66
3.45
6.78
2.0
1.6
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
11
17
6.38
6.62
1.4
1.2
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
17
40
4.20
6.56
1.0
1.0
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
57
268
2.13
6.49
2.7
10.0
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
141
884
1.62
6.41
7.6
5.5
ng/l
67.7
68.7
0.05
131
814
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
35
133
2.62
6.41
1.1
1.1
mg/l
244.7
203.7
0.89
35
118
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
18
46
3.87
6.25
1.7
2.1
umol/l
16.1
17.8
0.29
18
46
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
22
66
3.30
6.08
1.3
1.2
nmol/l
5.5
1.0
—
9
10
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
23
71
3.21
6.08
1.8
2.7
umol/l
124.8
157.9
0.22
13
38
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1110
9899
1.31
5.90
16.0
10.3
ml/min/173m2
94.3
93.6
0.38
885
7637
(3037121) Protein [Mass/volume] in Urine
93
536
1.74
5.82
4.4
5.9
g/l
0.2
0.3
2.80
58
326
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
51
242
2.10
5.71
1.9
2.3
g/l
3.3
3.3
0.13
40
189
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
51
243
2.09
5.65
2.0
2.3
g/l
9.9
9.9
0.00
40
206
(3019150) Specific gravity of Urine by Refractometry
358
2760
1.35
5.59
5.1
3.6
kg/l
1.0
1.0
2.45
48
415
(3003181) Sodium [Moles/volume] in Urine
45
205
2.19
5.58
3.7
1.9
mmol/l
78.4
71.8
0.33
35
174
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
13
28
4.58
5.58
1.1
1.1
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
53
258
2.05
5.56
1.9
2.2
g/l
3.7
3.7
0.03
39
184
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
40
174
2.29
5.54
3.0
3.6
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
53
259
2.04
5.50
1.9
2.2
g/l
7.7
7.5
0.33
39
192
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
46
215
2.13
5.37
2.0
2.3
g/l
36.7
37.9
0.50
38
181
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
8
5
15.77
5.35
1.0
1.0
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
32
128
2.48
5.33
1.1
1.1
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
42
190
2.20
5.31
2.1
2.5
g/l
0.0
0.0
0.00
36
173
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
41
184
2.22
5.29
2.8
3.5
e6/l
613.7
546.9
0.26
33
135
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
76
426
1.79
5.25
1.8
2.0
g/l
1.8
1.4
2.39
65
370
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
44
204
2.15
5.25
2.1
2.4
g/l
0.0
0.0
0.49
38
187
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
52
259
2.00
5.15
1.9
2.2
—
—
—
0
0
(4306422)
37
161
2.28
5.14
1.1
1.2
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
47
227
2.06
5.06
2.0
2.5
g/l
1.0
0.5
0.32
40
197
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
41
188
2.17
5.04
2.1
2.5
g/l
0.0
0.0
0.00
36
173
(1175426) CD3 cells/100 lymphocytes in Blood
40
182
2.19
5.01
3.0
3.5
%
70.0
69.7
0.03
40
177
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
42
195
2.14
5.00
1.6
1.3
u/ml
4.0
5.7
0.59
24
94
(3020682) Albumin/Creatinine [Ratio] in Urine
305
2334
1.35
4.96
3.7
4.2
mg/mmol
6.4
11.7
2.26
216
1571
(36660697) Celiac disease serology panel - Serum
211
1521
1.41
4.95
1.2
1.2
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
35
152
2.29
4.90
3.4
3.9
e6/l
473.1
328.7
0.68
26
91
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
40
184
2.16
4.88
2.8
3.5
e9/l
0.2
0.2
0.32
33
137
(3035350) Ketones [Presence] in Urine by Test strip
688
5869
1.26
4.85
4.9
3.5
estimate
0.0
0.0
0.00
94
1107
(3004588) Protein electrophoresis panel - Serum or Plasma
80
468
1.71
4.80
1.9
2.3
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
688
5879
1.25
4.75
7.0
4.8
estimate
0.0
0.0
0.50
103
1142
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
18
56
3.18
4.74
1.3
1.1
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
5
227
0.21
4.72
1.8
1.5
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
18
57
3.12
4.61
1.3
1.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
18
57
3.12
4.61
1.3
1.1
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
42
203
2.06
4.54
2.9
3.4
e9/l
1.5
1.4
0.17
34
123
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
44
217
2.02
4.51
1.9
1.5
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
21
74
2.81
4.50
1.0
1.0
u/l
1.4
1.0
—
9
35
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
18
58
3.07
4.49
1.3
1.1
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
50
260
1.91
4.42
2.0
1.7
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
163
1145
1.44
4.41
4.6
5.2
u/l
252.9
259.8
0.20
154
1086
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
81
487
1.66
4.41
2.5
2.4
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
107
689
1.56
4.41
2.6
2.5
ug/l
5.6
6.9
0.34
92
599
(3051611) Lipemic interference index of Serum or Plasma
33
147
2.23
4.38
2.8
4.1
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
162
1139
1.44
4.37
3.9
3.4
g/l
0.2
0.2
0.10
148
1079
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
18
59
3.02
4.37
1.3
1.2
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
18
59
3.02
4.37
1.3
1.1
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
108
701
1.55
4.31
2.0
1.9
u/l
6.1
6.6
0.30
70
504
(3012516) Albumin [Mass/volume] in Urine
289
2240
1.32
4.28
3.3
3.4
mg/l
922.5
254.2
0.89
213
1516
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
39
188
2.06
4.26
1.6
1.3
u/ml
6.7
5.3
0.12
21
70
(1761482) Bacteria [#/volume] in Urine by Culture
45
230
1.95
4.20
7.0
4.3
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
39
190
2.04
4.15
1.1
1.1
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
685
5934
1.23
3.96
5.0
3.5
estimate
0.0
0.0
0.50
100
1117
(3049233) Organic acids panel - Urine
11
28
3.87
3.86
1.0
1.4
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
478
3993
1.25
3.86
1.5
1.5
u/ml
3.4
2.6
0.27
101
884
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
12
33
3.59
3.81
2.0
1.6
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
41
211
1.93
3.78
2.1
1.7
—
—
—
0
0
(4268621)
29
131
2.19
3.76
2.8
2.5
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
31
144
2.13
3.76
1.7
1.4
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
7
8
8.62
3.72
1.0
1.0
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
276
2166
1.30
3.72
3.3
3.1
umol/l
7863.7
6535.6
0.16
240
1912
(4027681)
27
120
2.23
3.65
1.1
1.2
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
9
16
5.54
3.60
1.1
1.3
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
33
161
2.03
3.54
1.8
1.4
mosm/kgh2o
284.5
287.1
0.26
23
113
(3006653) Thiamine [Moles/volume] in Blood
14
45
3.07
3.53
1.4
1.4
nmol/l
205.7
126.6
1.60
14
45
(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum
7
9
7.66
3.51
1.4
1.6
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
40
210
1.89
3.50
2.0
1.9
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
43
232
1.84
3.46
1.8
1.8
—
—
—
0
0
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
6
6
9.84
3.45
1.0
1.8
nmol/l
10.5
18.9
—
6
6
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
9
17
5.22
3.45
1.3
1.2
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
81
522
1.55
3.39
1.7
1.3
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
31
577
0.52
3.37
1.2
1.5
—
—
—
0
0
(1616796) Gas panel - Central venous blood
45
249
1.79
3.35
3.4
4.0
—
—
—
0
0
(3013336) Amino acids [Identifier] in Serum or Plasma
15
52
2.85
3.35
1.6
2.9
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
15
52
2.85
3.35
1.1
1.1
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
55
323
1.69
3.34
2.5
1.8
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
72
455
1.58
3.29
2.1
1.8
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
47
266
1.76
3.26
2.3
2.1
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
12
37
3.20
3.24
1.8
1.5
—
—
—
0
0
(44790049)
39
210
1.84
3.18
2.7
1.8
—
—
—
0
0
(44790048)
39
210
1.84
3.18
2.7
1.8
—
—
—
0
0
(44790047)
39
210
1.84
3.18
2.7
1.8
—
—
—
0
0
(44806118)
39
210
1.84
3.18
2.7
1.8
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
167
1248
1.35
3.18
1.7
1.5
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
79
517
1.52
3.11
1.3
1.2
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
16
60
2.63
3.11
3.4
3.9
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
42
234
1.78
3.08
1.2
1.2
u/ml
31.9
26.4
—
5
16
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
48
279
1.71
3.05
11.3
7.6
u/ml
336.1
1178.0
—
9
26
(43055514) Macroprolactin [Presence] in Serum or Plasma
15
55
2.69
3.04
1.1
1.1
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
19
79
2.38
3.01
1.7
1.7
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
19
79
2.38
3.01
1.1
1.2
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
54
327
1.64
2.96
2.4
1.8
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
6
191
0.31
2.94
1.2
1.7
mmol/l
7.1
6.9
—
6
120
(4035726)
109
771
1.41
2.91
1.5
1.5
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
44
704
0.60
2.84
1.6
1.8
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
153
1151
1.34
2.81
3.8
3.0
g/l
9.7
9.8
0.10
148
1071
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
18
76
2.34
2.78
1.7
1.4
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
39
220
1.76
2.78
2.2
2.5
%
17.7
17.3
0.34
20
111
(3034860) Kappa light chains.free [Mass/volume] in Serum
35
191
1.82
2.77
2.0
3.5
mg/l
39.6
85.6
0.75
29
153
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
16
64
2.47
2.76
6.8
9.2
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
105
747
1.40
2.73
1.8
1.6
mu/l
432.1
307.7
1.89
95
667
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
35
192
1.81
2.73
2.0
3.5
mg/l
36.0
31.6
0.20
29
155
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
34
185
1.82
2.73
2.0
1.7
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
7
14
4.92
2.68
1.0
1.1
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
40
230
1.72
2.68
2.6
11.2
%
67.9
66.1
0.22
40
230
(3000570) Elastase.pancreatic [Mass/mass] in Stool
51
315
1.61
2.62
1.5
1.4
ug/g
304.5
339.1
0.65
30
161
(1761868) Lipid panel - Serum or Plasma
308
3550
0.82
2.62
2.6
2.3
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
96
680
1.41
2.58
2.4
1.9
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
27
139
1.92
2.57
1.1
1.7
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
44
264
1.65
2.54
2.0
2.5
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
5
7
7.02
2.51
1.4
1.1
—
—
—
0
0
(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method
21
100
2.07
2.47
2.5
2.0
nmol/l
0.1
0.1
0.21
15
72
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
143
1089
1.32
2.44
7.0
6.2
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
15
62
2.39
2.44
1.2
1.3
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
132
994
1.33
2.44
1.4
1.3
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
8
21
3.75
2.41
1.0
1.5
—
—
—
0
0
(3020891) Body temperature
57
370
1.53
2.39
8.4
4.9
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
15
63
2.35
2.36
4.3
5.1
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
8
22
3.58
2.32
1.6
1.4
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
106
1370
0.74
2.31
1.1
1.2
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
423
3651
1.18
2.31
1.6
1.6
g/l
2.0
2.0
0.09
217
2077
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
132
1003
1.32
2.30
1.4
1.2
iu/ml
81.0
136.7
1.34
35
347
(3011288) Drugs identified in Urine by Screen method
136
1038
1.31
2.30
4.5
2.7
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
37
219
1.67
2.27
5.4
4.9
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
90
646
1.39
2.27
2.3
1.8
iu/l
9.6
11.3
0.25
58
464
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
81
572
1.41
2.25
1.5
1.4
—
—
—
0
0
(3032641) Amino acids panel - Urine
8
23
3.42
2.22
1.1
1.3
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
81
574
1.40
2.21
1.4
1.2
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
61
410
1.48
2.20
1.2
1.3
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
58
820
0.68
2.18
1.3
1.2
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
10
36
2.74
2.12
2.2
1.9
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
16
73
2.16
2.11
1.9
1.2
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
224
2611
0.82
2.11
1.6
1.6
—
—
—
0
0
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
6
14
4.22
2.11
1.0
1.3
%
43.3
21.9
—
6
9
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
12
48
2.46
2.10
2.2
2.4
nmol/l
70.3
91.6
0.42
12
48
(40768797) Stomach Pathology biopsy report
160
1265
1.27
2.08
1.3
1.3
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
23
122
1.86
2.05
3.0
4.2
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
131
1012
1.29
2.05
2.4
2.1
nmol/l
12.5
12.2
0.08
114
864
(3016330) Potassium [Moles/time] in 24 hour Urine
5
10
4.92
2.04
1.2
1.1
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
9
31
2.86
2.02
7.0
3.8
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
50
329
1.51
2.02
1.4
1.3
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
24
131
1.81
1.97
1.3
1.1
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
97
1238
0.75
1.97
1.5
1.5
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
229
2642
0.83
1.95
1.8
1.9
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
50
332
1.49
1.94
1.1
1.1
—
—
—
0
0
(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
10
38
2.59
1.94
11.9
7.9
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
11
44
2.46
1.93
3.4
2.7
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
40
253
1.56
1.93
2.1
2.2
g/l
132.2
133.8
0.12
30
198
(3012501) Base excess in Blood by calculation
39
246
1.57
1.91
4.5
4.6
mmol/l
1.5
2.3
1.80
27
152
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
30
177
1.68
1.90
3.3
4.5
—
—
—
0
0
(4024509)
15
70
2.11
1.90
1.6
1.4
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
137
1078
1.27
1.87
1.6
1.3
u/ml
537.8
333.2
0.38
120
1004
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
19
98
1.91
1.86
1.0
1.2
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
95
713
1.33
1.85
3.1
3.3
pmol/l
4.7
4.8
0.59
85
631
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
55
378
1.44
1.82
1.9
1.8
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
18
92
1.93
1.81
4.9
5.2
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
51
346
1.46
1.80
1.7
1.3
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
50
338
1.47
1.80
10.2
7.8
iu/ml
346.6
433.7
—
8
39
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
12
4.10
1.79
1.0
1.1
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
7
23
2.99
1.76
10.1
9.3
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
7
23
2.99
1.76
1.1
1.8
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
18
93
1.91
1.76
5.2
2.3
—
—
—
0
0
(3011648) Oxygen content in Venous blood
23
129
1.76
1.75
3.0
17.2
%
12.3
11.5
0.41
23
129
(3019225) pH of Specimen
111
859
1.29
1.75
6.2
3.9
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
8
29
2.71
1.75
1.1
1.1
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
192
1583
1.22
1.74
1.5
1.4
titre
438.6
498.9
0.29
29
282
(40761535) Cells panel - Urine sediment
102
785
1.29
1.68
5.2
3.4
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
122
962
1.26
1.67
3.7
3.0
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
47
320
1.45
1.65
4.7
3.6
mmol/l
1.8
1.4
1.03
42
312
(3035933) Granulocytes/100 leukocytes in Blood
6
144
0.41
1.64
1.0
1.4
—
—
—
0
0
(3022621) pH of Urine by Test strip
92
701
1.30
1.64
3.4
2.8
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
42
593
0.69
1.63
1.4
1.6
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
90
1127
0.77
1.62
1.5
1.4
—
—
—
0
0
(4062490)
27
163
1.64
1.61
1.4
1.3
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
92
704
1.30
1.60
1.2
1.2
—
—
—
0
0
(4010399)
90
687
1.30
1.59
1.4
1.4
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
97
748
1.29
1.59
2.3
2.3
e9/l
4.0
4.2
0.23
75
620
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
5
14
3.51
1.58
1.2
1.5
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
151
1228
1.23
1.58
3.5
2.1
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
31
195
1.57
1.58
1.5
1.5
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
17
90
1.86
1.57
1.6
2.4
%
37.2
43.7
—
6
26
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
29
180
1.59
1.56
1.8
1.6
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
8
32
2.46
1.55
1.8
1.7
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
7
26
2.65
1.54
4.1
1.5
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
7
26
2.65
1.54
1.0
1.1
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
42
584
0.70
1.51
1.5
1.7
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
5
123
0.40
1.50
2.0
1.2
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
5
125
0.39
1.50
2.0
1.2
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
74
556
1.32
1.48
1.5
1.3
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
7
27
2.55
1.48
1.9
2.4
—
—
—
0
0
(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum
6
21
2.81
1.47
1.5
1.2
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
6
21
2.81
1.47
4.5
9.4
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
10
44
2.24
1.47
1.3
1.3
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
18
100
1.77
1.45
1.2
1.1
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
25
153
1.61
1.44
1.8
1.5
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
17
93
1.80
1.43
1.8
2.0
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
13
65
1.97
1.42
1.1
1.2
iu/ml
323.2
199.1
0.53
13
65
(3000492) Spirometry study
131
1064
1.23
1.41
1.5
1.4
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
10
45
2.19
1.40
2.1
2.3
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
44
307
1.42
1.40
1.1
1.1
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
220
1877
1.17
1.39
3.8
4.6
ug/l
3.7
2.9
0.29
194
1669
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
40
276
1.43
1.35
1.5
1.6
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
173
1452
1.19
1.34
3.4
2.0
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
24
149
1.59
1.32
3.7
3.3
nmol/l
0.7
0.8
0.90
19
116
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
38
520
0.71
1.29
1.5
1.5
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
25
158
1.56
1.28
1.2
1.3
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
21
127
1.63
1.28
2.0
1.5
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
117
952
1.22
1.26
3.0
2.7
u/l
11963.6
4969.1
0.79
31
354
(44806071)
5
18
2.73
1.26
1.0
1.1
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
252
2192
1.15
1.25
2.0
1.6
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
8
35
2.25
1.25
1.5
2.0
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
172
1456
1.18
1.22
4.3
4.2
%
26.6
21.2
2.97
68
639
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
10
48
2.05
1.22
8.3
7.1
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
10
48
2.05
1.22
7.0
7.0
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
6
25
2.36
1.21
1.0
1.3
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
113
921
1.22
1.21
4.7
4.5
%
0.8
0.8
0.02
31
262
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
20
122
1.62
1.19
1.6
2.1
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
5
19
2.59
1.19
1.6
1.4
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
56
420
1.32
1.18
1.7
1.8
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
91
1089
0.81
1.18
2.2
1.5
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
47
345
1.35
1.15
1.4
1.9
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
415
3750
1.11
1.13
2.0
1.9
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
13
71
1.80
1.13
1.4
1.6
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
25
164
1.50
1.12
1.1
1.3
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
11
57
1.90
1.11
2.2
1.7
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
7
30
2.29
1.11
1.9
4.0
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
14
79
1.75
1.10
1.1
1.1
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
32
222
1.42
1.09
1.1
1.2
—
—
—
0
0
(3034426) Prothrombin time (PT)
8
40
1.97
1.09
1.9
1.4
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
36
256
1.39
1.08
1.2
1.1
iu/ml
37.2
162.8
—
9
84
(3027944) Amphetamines [Presence] in Urine
179
1538
1.16
1.07
3.4
1.9
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
11
58
1.87
1.06
3.7
4.9
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
7
32
2.15
1.06
6.9
2.8
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
7
32
2.15
1.06
6.9
2.8
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
159
1786
0.86
1.04
1.6
1.5
—
—
—
0
0
(3002256) Pathology report gross observation
135
1138
1.18
1.03
1.2
1.2
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
181
1564
1.15
1.02
3.3
2.0
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
5
104
0.47
1.01
1.0
1.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
181
1566
1.15
1.00
3.4
2.0
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
60
467
1.27
1.00
2.7
1.8
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
57
441
1.28
0.99
2.8
1.8
u/ml
77.0
96.7
—
5
52
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
28
194
1.42
0.98
2.0
2.6
ug/min
216.7
126.0
0.28
23
122
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
13
75
1.71
0.97
1.1
1.1
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
37
271
1.35
0.95
2.5
2.6
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
12
68
1.74
0.95
1.0
1.4
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
13
76
1.68
0.93
1.0
1.4
e6/l
22382.9
43394.7
—
7
47
(3012441) Differential panel - Pleural fluid
13
76
1.68
0.93
1.0
1.5
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
29
205
1.39
0.92
1.9
1.4
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
6
27
2.18
0.92
1.5
1.2
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
101
842
1.19
0.90
4.4
4.1
%
0.5
0.5
0.03
20
183
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
6
28
2.11
0.90
1.2
1.1
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
55
671
0.80
0.89
1.5
1.5
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
243
2162
1.12
0.89
2.7
3.0
ug/g
136.2
128.1
0.16
198
1716
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
36
266
1.34
0.89
1.1
1.1
u/ml
3.5
3.0
0.09
13
104
(3022229) Phosphate [Moles/volume] in Urine
14
85
1.62
0.88
2.4
3.4
mmol/l
23.8
21.0
0.27
14
79
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
29
207
1.38
0.88
1.1
1.1
iu/ml
3.8
7.2
—
5
39
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
21
141
1.47
0.88
1.3
1.2
nmol/l
0.5
0.5
0.26
21
132
(3025018) Bordetella pertussis Ab [Titer] in Serum
28
199
1.39
0.87
1.2
1.2
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
8
42
1.87
0.87
1.8
3.1
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
91
1051
0.84
0.87
5.6
3.6
—
—
—
0
0
(3013512) EKG study
277
2488
1.11
0.86
6.1
3.4
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
8
43
1.83
0.86
5.3
5.6
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
6
30
1.97
0.85
1.0
1.4
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
27
360
0.73
0.85
1.1
1.1
u/ml
0.1
0.4
—
10
141
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
90
749
1.19
0.83
4.3
3.9
mmol/l
1.2
1.2
0.00
84
649
(3021788) Differential panel - Synovial fluid
10
163
0.60
0.83
1.3
1.6
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
42
321
1.29
0.83
1.3
1.1
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
50
391
1.26
0.83
1.3
2.0
u/l
32.6
38.9
1.76
44
356
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
10
56
1.76
0.83
1.4
1.3
—
—
—
0
0
(3008898) HLA-B27 [Presence]
48
588
0.80
0.82
1.1
1.1
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
38
287
1.31
0.82
1.4
2.2
nmol/l
1.1
0.6
0.91
32
243
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
14
87
1.58
0.82
1.4
1.2
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
26
346
0.73
0.82
1.2
1.1
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
177
1555
1.13
0.81
3.4
2.0
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
12
72
1.64
0.80
3.7
3.0
u/ml
1258.6
1104.8
0.14
12
72
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
6
32
1.84
0.80
1.2
1.2
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
103
872
1.17
0.79
4.8
4.5
%
0.0
0.1
0.99
29
241
(3003740) Influenza virus B Ag [Presence] in Specimen
26
344
0.74
0.79
1.2
1.1
—
—
—
0
0
(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence
0
24
0.00
0.79
0.0
1.4
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
5
95
0.51
0.78
1.0
1.2
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
17
113
1.48
0.76
2.5
1.6
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
13
81
1.58
0.76
2.9
5.1
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
16
105
1.50
0.76
1.1
1.6
umol/l
12.0
10.1
0.50
16
97
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
58
688
0.82
0.76
1.4
1.3
miu/ml
147.9
244.5
2.33
16
317
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
10
158
0.62
0.75
1.3
1.5
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
25
1.97
0.71
1.0
1.1
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
7
39
1.76
0.71
3.9
7.7
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
32
242
1.30
0.71
1.3
1.3
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
27
199
1.34
0.71
1.6
1.2
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
20
140
1.41
0.70
1.5
3.7
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
34
261
1.28
0.68
2.9
3.6
mmol/l
3.8
3.9
0.58
28
235
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
16
108
1.46
0.68
1.3
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
16
108
1.46
0.68
1.3
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
16
108
1.46
0.68
1.3
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
16
108
1.46
0.68
1.3
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
16
108
1.46
0.68
1.3
1.1
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
12
76
1.55
0.67
2.3
1.4
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
18
244
0.72
0.66
2.2
1.4
u/ml
18.7
12.2
—
10
148
(3000093) Morphology [Interpretation] in Blood Narrative
20
142
1.39
0.66
1.3
1.1
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
107
925
1.14
0.65
2.2
1.8
g/l
1.0
1.1
0.74
98
857
(1002224) Polysomnography panel
45
360
1.23
0.65
1.1
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
16
109
1.44
0.65
1.3
1.2
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
5
28
1.75
0.65
1.0
1.8
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
13
85
1.50
0.64
2.0
1.7
mmol/l
7.3
6.4
—
8
66
(3044927) Protein electrophoresis panel - Urine
12
77
1.53
0.64
1.1
1.1
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
54
442
1.21
0.64
1.7
1.7
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
118
1030
1.13
0.63
2.7
2.8
ug/l
0.7
0.7
0.19
81
643
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
24
307
0.76
0.62
1.2
1.2
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
185
1661
1.10
0.61
1.2
1.2
iu/ml
26.0
31.3
0.28
28
438
(3014765) Yersinia sp identified in Stool by Organism specific culture
52
426
1.20
0.61
1.4
1.2
—
—
—
0
0
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
0
19
0.00
0.60
0.0
1.7
—
7.5
—
0
11
(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma
15
103
1.43
0.60
2.7
2.2
mmol/l
1.5
1.9
—
10
80
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
8
51
1.54
0.59
1.5
1.5
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
51
594
0.84
0.59
1.5
1.4
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
150
1336
1.11
0.59
1.6
1.4
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
28
215
1.28
0.58
3.3
2.4
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
51
420
1.20
0.58
1.3
1.2
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
18
129
1.37
0.58
1.1
1.1
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
6
35
1.68
0.57
7.2
7.5
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
97
844
1.14
0.56
4.9
4.5
%
0.0
0.5
0.54
22
208
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
22
280
0.77
0.56
1.3
1.2
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
6
36
1.64
0.56
1.7
1.2
ug/l
12.7
9.6
—
6
36
(42529406) Shigella sp [Presence] in Stool by Culture
52
432
1.19
0.55
1.4
1.2
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
6
37
1.59
0.54
1.2
2.7
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
18
131
1.35
0.54
1.3
1.2
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
22
278
0.77
0.54
1.6
1.6
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
13
89
1.44
0.53
1.5
1.5
ug/l
5.4
5.4
0.00
13
82
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
12
81
1.46
0.53
1.3
1.2
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
26
201
1.27
0.52
1.4
1.2
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
9
62
1.43
0.52
1.8
1.2
—
—
—
0
0
(3027901) Hemoglobin [Mass/volume] in Arterial cord blood
9
62
1.43
0.52
1.0
1.0
g/l
170.9
164.9
—
9
62
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
52
596
0.85
0.52
1.5
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
52
596
0.85
0.52
1.5
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
52
596
0.85
0.52
1.5
1.4
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
303
2805
1.07
0.51
6.1
4.5
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
9
63
1.40
0.51
1.2
2.4
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
19
243
0.76
0.51
1.5
1.4
u/ml
12.2
3.5
0.34
12
155
(3022145) Colonoscopy Study observation
119
1057
1.11
0.51
1.4
1.4
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
60
509
1.16
0.51
1.8
1.7
mg/l
5.9
3.4
0.52
44
339
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
6
40
1.47
0.50
1.2
1.1
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
11
74
1.46
0.49
1.2
1.1
miu/ml
1702.2
1619.9
0.07
11
74
(40768443) Skin Pathology biopsy report
49
410
1.18
0.49
1.2
1.2
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
14
186
0.74
0.49
1.3
1.1
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
314
3250
0.94
0.48
4.9
3.1
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
13
91
1.40
0.48
1.1
1.1
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
7
107
0.64
0.48
7.1
5.3
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
7
107
0.64
0.48
3.6
2.6
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
15
108
1.37
0.48
3.1
1.7
pg
30.5
32.3
0.67
15
108
(4034850)
39
320
1.20
0.48
11.8
8.6
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
25
195
1.26
0.48
1.7
1.3
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
7
47
1.46
0.47
2.9
2.8
u/l
204.0
211.3
—
7
47
(3017704) Immunofixation for Urine
7
47
1.46
0.47
1.1
1.3
—
—
—
0
0
(3024932) HLA-DR beta [Type]
11
75
1.44
0.47
1.0
1.1
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
10
67
1.47
0.46
1.1
1.1
—
—
—
0
0
(3024471) HLA-A [Type]
11
76
1.42
0.44
1.0
1.0
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
7
50
1.38
0.44
1.0
1.2
g/l
0.3
0.3
—
7
44
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
5
30
1.64
0.43
1.0
1.3
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
121
1088
1.10
0.43
1.9
1.9
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1162
11229
1.05
0.41
3.6
3.7
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
79
696
1.12
0.41
4.2
3.8
ug/l
6.2
28.7
1.11
64
561
(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid
0
15
0.00
0.41
0.0
1.1
—
28.6
—
0
10
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
349
3579
0.95
0.41
2.9
2.5
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
468
4426
1.05
0.41
5.6
3.5
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
16
0.00
0.41
0.0
1.4
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
5
33
1.49
0.40
1.4
2.4
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
0
17
0.00
0.40
0.0
2.4
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
21
255
0.81
0.40
3.2
3.3
mg/l
30.2
27.3
0.11
13
156
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
8
59
1.33
0.40
1.3
1.4
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
8
60
1.31
0.39
1.3
1.4
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
18
139
1.27
0.39
2.0
1.8
—
—
—
0
0
(44813793)
19
148
1.26
0.38
1.1
1.1
—
—
—
0
0
(3004451) EKG impression Narrative
5
35
1.40
0.38
1.4
1.2
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
12
87
1.36
0.38
4.7
3.7
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
9
65
1.36
0.38
1.8
1.2
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
77
682
1.11
0.38
2.7
2.6
ml/min/173m2
72.7
73.1
0.02
21
262
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
11
79
1.37
0.37
1.3
1.0
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
6
41
1.44
0.35
1.2
1.1
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
6
41
1.44
0.35
5.8
4.8
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
325
3322
0.95
0.35
2.6
2.3
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
35
296
1.16
0.34
3.8
3.2
u/ml
1626.5
1331.3
0.11
30
248
(3024522) Salmonella sp identified in Specimen by Organism specific culture
18
142
1.25
0.34
1.3
1.4
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
19
151
1.24
0.34
1.4
1.4
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
6
44
1.34
0.34
1.7
1.6
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
335
3161
1.05
0.33
1.9
1.7
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
37
416
0.87
0.33
1.2
1.1
u/ml
10.4
7.0
0.29
16
219
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
16
125
1.26
0.33
1.2
1.2
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
6
46
1.28
0.32
1.7
1.5
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
86
775
1.09
0.32
1.6
1.2
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
59
641
0.90
0.31
1.2
1.2
u/ml
6.2
6.9
0.12
40
442
(3023430) Cat dander IgE Ab [Units/volume] in Serum
34
383
0.87
0.31
1.2
1.1
u/ml
11.1
9.4
0.15
18
221
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
10
129
0.76
0.31
3.6
2.7
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
18
144
1.23
0.31
1.3
1.4
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
34
381
0.87
0.30
5.6
3.5
umol/l
12.7
7.6
1.14
24
310
(3044242) Glucose [Moles/volume] in Arterial blood
7
54
1.27
0.30
2.4
2.7
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
18
145
1.22
0.29
1.3
1.4
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
58
625
0.91
0.28
1.2
1.2
u/ml
2.1
1.2
0.30
36
399
(40768441) Liver Pathology biopsy report
9
114
0.77
0.27
1.9
1.5
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
9
118
0.75
0.27
1.3
1.1
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
8
66
1.19
0.26
1.4
1.3
g/l
1.1
0.9
—
8
66
(3008757) Leukocyte morphology finding [Identifier] in Blood
15
178
0.83
0.25
4.5
4.2
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
41
361
1.12
0.25
1.3
1.4
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
17
139
1.20
0.25
1.4
1.4
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
16
130
1.21
0.25
1.0
1.0
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
9
75
1.18
0.24
1.0
1.6
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
423
4045
1.04
0.24
1.6
1.6
—
—
—
0
0
(3022670) pH of Venous cord blood
5
37
1.33
0.23
1.0
1.0
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
12
144
0.82
0.23
1.7
1.5
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
30
261
1.13
0.22
1.2
1.1
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
7
91
0.75
0.22
1.0
1.1
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
17
141
1.18
0.22
1.3
1.4
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
5
41
1.20
0.21
1.4
1.4
—
—
—
0
0
(21494434) Karyotype in Bone marrow
13
105
1.22
0.21
1.5
1.1
—
—
—
0
0
(3042552) Rheumatoid factor [Units/volume] in Pleural fluid
0
10
0.00
0.21
0.0
1.0
—
10.8
—
0
5
(3014891) Appearance of Pleural fluid
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
0
11
0.00
0.21
0.0
1.7
—
1.8
—
0
5
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
5.3
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3014591) Smooth Alder IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3017461) Flecainide [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
3.4
—
0.5
—
0
12
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
17
142
1.18
0.21
1.3
1.4
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
41
441
0.91
0.21
1.8
1.9
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
43
460
0.91
0.20
1.5
1.5
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
35
311
1.11
0.19
1.4
1.1
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
17
143
1.17
0.19
1.3
1.4
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
12
141
0.83
0.19
1.8
1.7
%
12.6
12.9
0.74
12
141
(3000012) Reticulocyte production index
6
50
1.18
0.19
1.5
1.9
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
43
459
0.92
0.19
1.5
1.5
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
6
51
1.15
0.19
1.0
1.0
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
6
51
1.15
0.19
1.7
3.1
—
—
—
0
0
(3016031) Almond IgE Ab [Units/volume] in Serum
6
52
1.13
0.18
1.2
1.1
u/ml
1.8
1.8
—
6
40
(3012494) Peanut IgE Ab [Units/volume] in Serum
16
182
0.86
0.18
1.2
1.3
u/ml
133.5
21.1
0.42
11
144
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
162
1651
0.96
0.18
2.7
2.1
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
125
1173
1.05
0.18
1.1
1.1
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
115
1077
1.05
0.18
4.8
3.6
%
32.3
32.0
0.09
93
740
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
17
192
0.87
0.18
1.1
1.1
g/l
1.4
1.4
0.38
17
173
(3017315) Amylase [Enzymatic activity/volume] in Urine
7
57
1.21
0.18
1.3
1.2
u/l
354.6
527.2
—
7
50
(46235355) HIV 1 and 2 tests - Meaningful Use set
434
4173
1.03
0.18
2.3
2.2
—
—
—
0
0
(4094501)
19
163
1.15
0.18
1.0
1.1
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
12
139
0.85
0.17
1.8
2.0
—
—
—
0
0
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
7
62
1.11
0.17
1.1
1.0
—
12.9
—
0
12
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
52
476
1.07
0.16
1.4
1.6
iu/ml
26.9
10.2
0.24
13
118
(3007566) Smooth muscle Ab [Titer] in Serum
34
364
0.91
0.16
1.6
1.5
titre
46.7
57.4
—
6
34
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
8
68
1.16
0.16
2.1
1.8
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
8
69
1.14
0.16
1.3
1.1
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
11
91
1.19
0.15
1.2
1.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
11
91
1.19
0.15
1.2
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
11
91
1.19
0.15
1.2
1.6
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
59
613
0.94
0.14
2.3
1.7
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
7
85
0.81
0.14
1.0
1.0
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
7
85
0.81
0.14
1.3
1.2
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
7
85
0.81
0.14
1.0
1.0
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
7
86
0.80
0.14
1.4
1.6
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
77
792
0.95
0.14
1.4
1.4
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
14
120
1.15
0.13
1.3
1.2
nmol/l
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
45
470
0.94
0.13
1.5
1.5
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
23
205
1.10
0.13
1.3
1.5
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
9
105
0.84
0.13
9.8
2.6
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
9
105
0.84
0.13
9.8
2.5
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
59
608
0.95
0.12
1.2
1.2
u/ml
4.6
3.7
0.13
15
198
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
16
140
1.12
0.12
1.3
1.2
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
18
195
0.90
0.11
1.1
1.1
—
—
—
0
0
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
14
154
0.89
0.11
1.2
1.3
—
218.8
—
0
8
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
73
688
1.04
0.10
1.3
1.2
u/ml
3.7
2.3
0.30
46
403
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
199
1994
0.98
0.10
3.0
2.3
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
19
170
1.10
0.10
1.7
1.4
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
63
595
1.04
0.09
2.4
1.6
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
32
296
1.06
0.08
1.7
1.8
iu/l
2.5
5.4
2.05
12
103
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
6
55
1.07
0.08
1.2
1.2
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
6
55
1.07
0.08
1.2
1.1
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
6
55
1.07
0.08
1.2
1.2
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
6
55
1.07
0.08
1.2
1.2
—
—
—
0
0
(4211845)
6
56
1.05
0.08
1.7
3.0
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
443
4392
0.99
0.08
1.9
1.8
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
5
63
0.78
0.08
4.4
5.2
—
221.8
—
0
14
(4281824)
7
63
1.09
0.08
1.0
1.1
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
7
66
1.04
0.08
1.6
1.5
%
39.1
32.4
—
7
48
(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum
10
110
0.89
0.07
1.3
1.2
u/ml
7.3
6.4
—
10
99
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
11
120
0.90
0.07
1.6
2.8
—
—
—
0
0
(4146454)
7
79
0.87
0.07
3.1
2.8
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
9
85
1.04
0.07
1.2
1.2
—
—
—
0
0
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
8
89
0.88
0.06
1.1
1.0
—
9.9
—
0
7
(3000475) Leukocytes [#/volume] in Synovial fluid
23
212
1.07
0.06
1.7
1.7
e6/l
22243.4
15284.9
0.37
18
151
(3039443) Prostate specific Ag panel - Serum or Plasma
9
101
0.87
0.06
1.0
1.5
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
10
88
1.12
0.06
3.1
2.0
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
29
271
1.05
0.06
4.3
3.8
%
53.9
54.2
0.03
29
271
(3045142) Bone marrow Pathology biopsy report
14
127
1.08
0.05
1.4
1.4
—
—
—
0
0
(40768793) Breast Pathology biopsy report
17
178
0.94
0.05
1.3
1.3
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
16
168
0.93
0.05
2.6
1.9
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
319
3103
1.01
0.05
5.7
3.7
estimate
0.0
0.0
0.88
99
1105
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
10
89
1.10
0.04
2.4
1.2
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
33
312
1.04
0.04
2.0
1.4
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
11
99
1.09
0.04
1.4
1.6
%
58.4
64.3
0.21
11
77
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
33
313
1.04
0.03
3.9
1.9
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
26
264
0.97
0.02
3.3
3.6
e9/l
3.7
3.7
0.01
26
264
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
60
579
1.02
0.02
2.5
1.7
u/ml
212.4
193.4
0.20
34
300
(3011841) English Walnut IgE Ab [Units/volume] in Serum
11
114
0.95
0.01
1.2
1.2
u/ml
0.6
14.7
2.64
11
103
(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood
17
173
0.96
0.01
1.1
1.0
mmol/l
19.1
19.6
0.55
17
168
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
56
543
1.01
0.00
1.3
1.4
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
10
101
0.97
0.00
1.8
1.3
—
—
—
0
0
(3006598) pH of Arterial cord blood
17
167
1.00
0.00
1.1
1.0
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
27
263
1.01
0.00
1.3
1.1
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
10
97
1.01
0.00
1.2
1.2
%
100.0
80.0
—
10
97
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
162
1587
1.00
0.00
1.2
1.2
u/ml
4.7
9.8
0.93
50
554
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
10
96
1.02
0.00
1.2
1.2
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
12
120
0.98
0.00
1.0
1.0
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
9
0.00
0.00
0.0
1.2
—
1.9
—
0
9
(40763590) HLA-DQ beta [Type]
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025315) Body weight
0
9
0.00
0.00
0.0
2.8
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
0
6
0.00
0.00
0.0
8.7
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011544) Albumin [Mass/volume] in Pleural fluid
0
9
0.00
0.00
0.0
1.0
—
18.3
—
0
9
(3004347) Hepatitis D virus Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013862) HLA-DP [Type]
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(3022475) Manganese [Moles/volume] in Blood
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009677) Dengue virus Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020093) Fractional oxyhemoglobin in Venous cord blood
0
5
0.00
0.00
0.0
1.0
—
77.3
—
0
5
(43055187) t(12;21)(p13;q22.3)(ETV6,RUNX1) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method
0
5
0.00
0.00
0.0
4.0
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
5
53
0.93
0.00
1.2
1.3
—
—
—
0
0
(3023436) Glucagon [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.4
—
186.4
—
0
5
(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
8
82
0.96
0.00
1.3
1.2
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
6
58
1.02
0.00
1.3
1.2
—
1.4
—
0
5
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
9
97
0.91
0.00
1.0
1.0
—
—
—
0
0
(3027305) Fractional oxyhemoglobin in Arterial cord blood
0
7
0.00
0.00
0.0
1.0
—
37.0
—
0
7
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
0
5
0.00
0.00
0.0
1.4
—
4.3
—
0
5
(36303722) Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.4
—
24.4
—
0
5
(3007919) Fasciola sp Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.4
—
41.6
—
0
8
(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine
0
5
0.00
0.00
0.0
1.0
—
550.8
—
0
5
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3021374) Sirolimus [Mass/volume] in Blood
0
5
0.00
0.00
0.0
8.4
—
6.7
—
0
5
(40763791) Oxygen content in Venous blood by calculation
0
8
0.00
0.00
0.0
16.8
—
13.5
—
0
8
(3029612) Listeria sp Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003157) Bacteria [#/volume] in Mother's milk
0
7
0.00
0.00
0.0
9.0
—
—
—
0
0
(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: F5_SPECIFIC_SPEECH – Disorders of speech understanding and production
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).